Analyst Upgrades Integer Holdings to Buy Rating
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 48 minutes ago
0mins
Should l Buy ITGR?
Source: Fool
- Rating Upgrade: Oppenheimer analyst Suraj Kalia upgraded Integer Holdings from hold to outperform, setting a price target of $115 per share, reflecting optimism about the company's future performance.
- Strategic Review: Integer's recent announcement of a 'strategic review' indicates potential consideration for a sale to an outside party, which could result in a premium transaction above the current price, enhancing shareholder value.
- Market Appeal: As a contract development and manufacturing organization for medical devices, Integer's modest valuations and share price make it an attractive acquisition target for private equity firms, with Kalia's research indicating interest from several in this sector.
- Profitability Potential: Operating in a limited but profitable niche, Integer typically achieves top-line growth and high net margins, and as potential investor interest grows, this 'sleeping stock' may see significant market activity.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ITGR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ITGR
Wall Street analysts forecast ITGR stock price to rise
4 Analyst Rating
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 84.980
Low
75.00
Averages
86.25
High
95.00
Current: 84.980
Low
75.00
Averages
86.25
High
95.00
About ITGR
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analyst Upgrades Integer Holdings to Buy Rating
- Rating Upgrade: Oppenheimer analyst Suraj Kalia upgraded Integer Holdings from hold to outperform, setting a price target of $115 per share, reflecting optimism about the company's future performance.
- Strategic Review: Integer's recent announcement of a 'strategic review' indicates potential consideration for a sale to an outside party, which could result in a premium transaction above the current price, enhancing shareholder value.
- Market Appeal: As a contract development and manufacturing organization for medical devices, Integer's modest valuations and share price make it an attractive acquisition target for private equity firms, with Kalia's research indicating interest from several in this sector.
- Profitability Potential: Operating in a limited but profitable niche, Integer typically achieves top-line growth and high net margins, and as potential investor interest grows, this 'sleeping stock' may see significant market activity.
See More
Wall Street's Latest Ratings Overview
- Nvidia's Positive Outlook: Oppenheimer reiterates Nvidia as an outperform, projecting CY26 free cash flow to approach $200 billion, and if half is allocated for dividends, the yield could reach nearly 2.5%, which would bolster investor confidence and drive stock price appreciation.
- Apple's Strong Ecosystem: Daiwa raises Apple's price target from $310 to $325, emphasizing its vast ecosystem as a core strength, while acknowledging potential memory management challenges in 2H CY26, the long-term outlook remains favorable for this core holding.
- Positive Outlook for Housing Platform: UBS upgrades KE Holdings to buy from neutral, citing significant upside due to its agency business in tier 1 cities, particularly as the market recovery is led by the secondary market, positioning the company for strong performance.
- Wendy's Potential Privatization: Argus upgrades Wendy's to buy from neutral, driven by news of a potential move to take the restaurant chain private, with Trian Fund Management owning about 40% of the stock, indicating strong market confidence in this strategic shift.
See More
Integer Holdings Q1 2026 Earnings Call Insights
- Weak Sales Growth: Integer Holdings reported Q1 sales of $440 million, reflecting a 0.5% year-over-year increase, but the 2026 sales outlook has been revised down to $1.805 billion to $1.835 billion due to customer forecast updates, indicating signs of market demand weakness that could impact future profitability.
- Declining Profitability: Adjusted earnings per share fell to $1.20, down 8% year-over-year, while adjusted EBITDA decreased to $85 million, a $7 million drop from the previous year, highlighting the pressure on profitability amid changing market conditions and cost management challenges.
- Strategic Review Initiated: The company's board has initiated a strategic review without a set timeline, signaling heightened market interest in Integer Holdings, which could pave the way for potential mergers or restructuring in the future.
- Shift in Cost Management: Management indicated a shift towards more aggressive cost management strategies, as the adjusted operating margin contracted to 13.9% in Q1, with plans to optimize expenditures in the coming months to address the lowered sales outlook.
See More
Integer Holdings Initiates Strategic Review for Potential Sale or Merger
- Strategic Review Initiated: Integer Holdings (ITGR) has commenced a strategic review to explore options such as a potential sale, merger, or business combination, or continuing its current standalone plan to unlock more shareholder value, indicating the company's openness to external interest and strategic opportunities.
- Financial Performance Beats Expectations: For Q1 FY26, ITGR reported revenue of $440 million, a 0.6% year-over-year increase, exceeding estimates by $14 million, with a non-GAAP EPS of $1.20, surpassing the consensus estimate by $0.01, reflecting the company's solid position in the medical device manufacturing sector.
- Uncertain Future Outlook: Management noted that there is no fixed timeline for any potential deal and no guarantee that any transaction will occur, suggesting that the company remains in an exploratory phase regarding its strategic options, which may impact investor confidence.
- Stock Price Fluctuation: ITGR's stock is trading slightly lower at approximately $83 in premarket hours, reflecting market uncertainty regarding the company's future strategic direction, which could influence short-term investment decisions.
See More
Integer Holdings Q1 Earnings Exceed Expectations
- Earnings Beat: Integer Holdings reported a Q1 non-GAAP EPS of $1.20, exceeding expectations by $0.01, which reflects the company's robust profitability and boosts investor confidence.
- Revenue Growth: The company achieved Q1 revenue of $440 million, a 0.6% year-over-year increase, surpassing market expectations by $14 million, indicating its ability to maintain stable revenue streams in a competitive environment.
- Future Outlook: Integer Holdings anticipates organic sales growth of flat to 3% for 2026, despite headwinds from three new products, reflecting a cautiously optimistic view of future market conditions.
- Investor Conference: The company presented its strategic plans at the 47th Annual Raymond James Institutional Investor Conference, further enhancing market confidence in its long-term growth potential.
See More
INTEGER FY ADJUSTED EPS PROJECTION RANGES FROM USD 5.83 TO 6.40
- Economic Outlook: The integer outlook for FY is projected to be between 5.83 and 6.4, indicating a moderate growth expectation.
- Market Adjustments: Adjustments in economic forecasts suggest a need for businesses to adapt to changing market conditions.
- Investment Strategies: Investors are advised to consider diversified strategies to navigate potential fluctuations in the economy.
- Future Projections: Analysts emphasize the importance of monitoring economic indicators to refine future projections and strategies.
See More
Analyst Upgrades Integer Holdings to Buy Rating
- Rating Upgrade: Oppenheimer analyst Suraj Kalia upgraded Integer Holdings from hold to outperform, setting a price target of $115 per share, reflecting optimism about the company's future performance.
- Strategic Review: Integer's recent announcement of a 'strategic review' indicates potential consideration for a sale to an outside party, which could result in a premium transaction above the current price, enhancing shareholder value.
- Market Appeal: As a contract development and manufacturing organization for medical devices, Integer's modest valuations and share price make it an attractive acquisition target for private equity firms, with Kalia's research indicating interest from several in this sector.
- Profitability Potential: Operating in a limited but profitable niche, Integer typically achieves top-line growth and high net margins, and as potential investor interest grows, this 'sleeping stock' may see significant market activity.
See More
Wall Street's Latest Ratings Overview
- Nvidia's Positive Outlook: Oppenheimer reiterates Nvidia as an outperform, projecting CY26 free cash flow to approach $200 billion, and if half is allocated for dividends, the yield could reach nearly 2.5%, which would bolster investor confidence and drive stock price appreciation.
- Apple's Strong Ecosystem: Daiwa raises Apple's price target from $310 to $325, emphasizing its vast ecosystem as a core strength, while acknowledging potential memory management challenges in 2H CY26, the long-term outlook remains favorable for this core holding.
- Positive Outlook for Housing Platform: UBS upgrades KE Holdings to buy from neutral, citing significant upside due to its agency business in tier 1 cities, particularly as the market recovery is led by the secondary market, positioning the company for strong performance.
- Wendy's Potential Privatization: Argus upgrades Wendy's to buy from neutral, driven by news of a potential move to take the restaurant chain private, with Trian Fund Management owning about 40% of the stock, indicating strong market confidence in this strategic shift.
See More
Integer Holdings Q1 2026 Earnings Call Insights
- Weak Sales Growth: Integer Holdings reported Q1 sales of $440 million, reflecting a 0.5% year-over-year increase, but the 2026 sales outlook has been revised down to $1.805 billion to $1.835 billion due to customer forecast updates, indicating signs of market demand weakness that could impact future profitability.
- Declining Profitability: Adjusted earnings per share fell to $1.20, down 8% year-over-year, while adjusted EBITDA decreased to $85 million, a $7 million drop from the previous year, highlighting the pressure on profitability amid changing market conditions and cost management challenges.
- Strategic Review Initiated: The company's board has initiated a strategic review without a set timeline, signaling heightened market interest in Integer Holdings, which could pave the way for potential mergers or restructuring in the future.
- Shift in Cost Management: Management indicated a shift towards more aggressive cost management strategies, as the adjusted operating margin contracted to 13.9% in Q1, with plans to optimize expenditures in the coming months to address the lowered sales outlook.
See More
Integer Holdings Initiates Strategic Review for Potential Sale or Merger
- Strategic Review Initiated: Integer Holdings (ITGR) has commenced a strategic review to explore options such as a potential sale, merger, or business combination, or continuing its current standalone plan to unlock more shareholder value, indicating the company's openness to external interest and strategic opportunities.
- Financial Performance Beats Expectations: For Q1 FY26, ITGR reported revenue of $440 million, a 0.6% year-over-year increase, exceeding estimates by $14 million, with a non-GAAP EPS of $1.20, surpassing the consensus estimate by $0.01, reflecting the company's solid position in the medical device manufacturing sector.
- Uncertain Future Outlook: Management noted that there is no fixed timeline for any potential deal and no guarantee that any transaction will occur, suggesting that the company remains in an exploratory phase regarding its strategic options, which may impact investor confidence.
- Stock Price Fluctuation: ITGR's stock is trading slightly lower at approximately $83 in premarket hours, reflecting market uncertainty regarding the company's future strategic direction, which could influence short-term investment decisions.
See More
Integer Holdings Q1 Earnings Exceed Expectations
- Earnings Beat: Integer Holdings reported a Q1 non-GAAP EPS of $1.20, exceeding expectations by $0.01, which reflects the company's robust profitability and boosts investor confidence.
- Revenue Growth: The company achieved Q1 revenue of $440 million, a 0.6% year-over-year increase, surpassing market expectations by $14 million, indicating its ability to maintain stable revenue streams in a competitive environment.
- Future Outlook: Integer Holdings anticipates organic sales growth of flat to 3% for 2026, despite headwinds from three new products, reflecting a cautiously optimistic view of future market conditions.
- Investor Conference: The company presented its strategic plans at the 47th Annual Raymond James Institutional Investor Conference, further enhancing market confidence in its long-term growth potential.
See More
INTEGER FY ADJUSTED EPS PROJECTION RANGES FROM USD 5.83 TO 6.40
- Economic Outlook: The integer outlook for FY is projected to be between 5.83 and 6.4, indicating a moderate growth expectation.
- Market Adjustments: Adjustments in economic forecasts suggest a need for businesses to adapt to changing market conditions.
- Investment Strategies: Investors are advised to consider diversified strategies to navigate potential fluctuations in the economy.
- Future Projections: Analysts emphasize the importance of monitoring economic indicators to refine future projections and strategies.
See More
